<p>Doximity（紐約證券交易所代碼：DOCS - 獲取免費報告）在週四發佈給投資者的報告中，摩根大通將其目標價格從 33.00 美元下調至 28.00 美元。該公司目前對該股票的評級為 “中性”。摩根大通的目標價格暗示該公司股價有 60.38% 的潛在上漲空間。</p>
<ul>
<li>Doximity 是醫療社區的 Facebook 和 LinkedIn</li>
</ul>
<p>其他幾家券商也最近對 DOCS 發表了評論。羅伯特·W·貝爾德在週四的報告中重申了 “中性” 評級，並將 Doximity 的目標價格設定為 18.00 美元（從 40.00 美元下調）。BMO 資本市場將 Doximity 的目標價格從 25.00 美元下調至 20.00 美元，並在週四的報告中對該公司給予 “市場表現” 評級。美國銀行將 Doximity 的目標價格從 56.00 美元下調至 47.00 美元，並在 4 月 16 日的研究報告中對該公司給予 “買入” 評級。Needham &amp; Company LLC 將 Doximity 的目標價格從 55.00 美元下調至 27.00 美元，並在週四的研究報告中對該公司給予 “買入” 評級。最後，傑弗瑞金融集團將 Doximity 的評級從 “買入” 下調至 “持有”，併為該公司設定了 19.00 美元的目標價格。兩位分析師對該股票給予了強烈買入評級，八位給予了買入評級，十三位對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，共識目標價格為 31.48 美元。</p>
<p><strong>查看我們對 Doximity 的最新股票分析</strong></p>
<h2>Doximity 股票表現</h2>
<ul>
<li>Doximity 是一個被忽視的醫療生態系統 AI 投資</li>
</ul>
<p>週四，DOCS 股票下跌 5.93 美元，跌至 17.46 美元。該公司共交易了 17,685,978 股股票，而其平均交易量為 3,604,347 股。Doximity 的 1 年最低價為 17.15 美元，1 年最高價為 76.51 美元。該公司的市值為 32.2 億美元，市盈率為 14.64，市盈增長比率為 1.88，貝塔值為 1.36。該股票的 50 日移動平均線為 24.27 美元。</p>
<p>Doximity 宣佈其董事會於 2 月 5 日啓動了一項股票回購計劃，允許公司回購 5 億美元的股票。該回購授權允許公司通過公開市場購買最多 8% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>內部活動</h2>
<ul>
<li>Doximity 股票是一個有趣的醫療投資</li>
</ul>
<p>在其他 Doximity 新聞中，內部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股股票，平均售價為 25.77 美元，總價值為 59,502.93 美元。出售完成後，該內部人士持有 89,396 股公司股票，價值約為 2,303,734.92 美元。這代表其持股減少了 2.52%。該交易在向證券交易委員會的備案中披露，相關信息可通過此鏈接獲取。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。此外，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股股票，平均售價為 26.06 美元，總交易額為 234,540.00 美元。出售完成後，該董事持有 19,839 股公司股票，價值約為 517,004.34 美元。該交易使其持股減少了 31.21%。該出售的 SEC 備案提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。在過去三個月中，內部人士出售了價值 456,061 美元的 18,055 股公司股票。公司內部人士持有公司股票的 31.30%。</p>
<h2>機構投資者對 Doximity 的看法</h2>
<p>一些對沖基金和其他機構投資者最近增加或減少了對該股票的持股。先鋒集團在第四季度將其在 Doximity 的持股增加了 4.1%。先鋒集團目前持有 13,285,485 股公司股票，價值 588,281,000 美元，在上個季度又增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度購買了 Doximity 的新頭寸，價值約為 4,572,000 美元。瑞銀集團在第四季度將其在 Doximity 的持股增加了 26.5%。瑞銀集團目前持有 680,260 股公司股票，價值 30,122,000 美元，在上個季度又增持了 142,408 股。Blair William &amp; Co. IL 在第三季度將其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前持有 362,740 股公司股票，價值 26,534,000 美元，在上個季度又增持了 345,390 股。最後，William Blair Investment Management LLC 在第三季度將其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前持有 5,829,169 股公司股票，價值 426,404,000 美元，在上個季度又增持了 609,775 股。對沖基金和其他機構投資者持有公司股票的 87.19%。</p>
<h2>更多 Doximity 新聞</h2>
<p>以下是本週影響 Doximity 的主要新聞故事：</p>
<ul>
<li>積極情緒：Doximity 報告調整後每股收益為 0.26 美元，超過了較低的分析師預期 0.17 美元，收入同比增長 5.1%，達到 1.4537 億美元，顯示出業務仍在增長。Doximity 財報</li>
<li>積極情緒：管理層表示，人工智能工具的採用和大型客户的增長促進了參與度，公司強調了創紀錄的自由現金流和持續的人工智能整合努力。Doximity 2026 財年第四季度財報電話會議要點</li>
<li>中性情緒：華爾街分析師通過下調目標價作出回應，但大多數保持中性至積極評級，表明該股票可能被視為超賣，而不是基本面破裂。分析師目標價更新</li>
<li>消極情緒：更大的擔憂是，Doximity 2027 財年的收入指引為 6.64 億至 6.76 億美元，低於 6.96 億美元的共識，指向比投資者預期更慢的增長前景。Doximity 2026 財年第四季度財報電話會議記錄</li>
<li>消極情緒：2027 財年第一季度收入指引為 1.51 億至 1.52 億美元，也未達到預期，進一步加深了對增長放緩和與人工智能相關的投資對利潤率施加壓力的擔憂。Doximity 因疲軟的指引大幅下跌</li>
<li>消極情緒：額外的情緒壓力來自於異常的看跌期權購買和披露的內部人士股票出售，這兩者都可能在交易者中發出謹慎信號。內部交易披露</li>
</ul>
<h2>關於 Doximity</h2>
<p>(獲取免費報告)</p>
<p>Doximity（股票代碼：DOCS）運營一個數字專業網絡和通信平台，主要為臨牀醫生設計。公司總部位於舊金山，連接醫生、護士執業者、醫師助理和其他醫療專業人員，提供簡化臨牀溝通、遠程醫療交付和獲取專業特定醫療信息的工具。其平台被定位為一個專業中心，臨牀醫生可以在此管理工作流程、跟進醫學新聞並與同行安全協作。</p>
<p>該公司的產品包括安全消息傳遞和視頻遠程醫療功能，使臨牀醫生能夠在保護患者信息的同時與患者和同事進行諮詢。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Doximity</li>
<li>YETI 在財報超預期和上調前景後反彈</li>
<li>三家領先量子公司的 Q1 財報對比</li>
<li>思科的垂直反彈可能仍處於早期階段</li>
<li>亞馬遜與阿里巴巴：現在顯然更具價值的選擇</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Doximity 嗎？</h2>
<p>在考慮 Doximity 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Doximity 並不在名單上。</p>
<p>雖然 Doximity 目前在分析師中獲得中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

摩根大通

DOCS

LGHT

HEAL

<p>摩根大通已將 Doximity（NYSE:DOCS）的目標股價從 33.00 美元下調至 28.00 美元，維持 “中性” 評級。這表明與前一交易日收盤價相比，仍有 60.38% 的上漲潛力。其他券商也調整了他們的目標價，羅伯特·W·貝爾德設定的目標為 18.00 美元，BMO 資本市場為 20.00 美元，美銀為 47.00 美元。Doximity 的股票交易價格下跌至 17.46 美元，市值為 32.2 億美元。內部人士最近出售了股份，顯示出對該股票估值的潛在擔憂</p>

<p>Doximity (NYSE:DOCS - Get Free Report) had its price objective decreased by research analysts at JPMorgan Chase &amp; Co. from $33.00 to $28.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a &#34;neutral&#34; rating on the stock. JPMorgan Chase &amp; Co.'s price target would suggest a potential upside of 60.38% from the company's previous close.</p>
<div class="lb-trans"><p>Doximity（紐約證券交易所代碼：DOCS - 獲取免費報告）在週四發佈給投資者的報告中，摩根大通將其目標價格從 33.00 美元下調至 28.00 美元。該公司目前對該股票的評級為 “中性”。摩根大通的目標價格暗示該公司股價有 60.38% 的潛在上漲空間。</p>
</div><ul>
<li>Doximity is the Facebook and LinkedIn of the Medical Community</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是醫療社區的 Facebook 和 LinkedIn</li>
</ul>
</div><p>Several other brokerages also recently commented on DOCS. Robert W. Baird reaffirmed a &#34;neutral&#34; rating and set a $18.00 target price (down from $40.00) on shares of Doximity in a report on Thursday. BMO Capital Markets reduced their target price on Doximity from $25.00 to $20.00 and set a &#34;market perform&#34; rating for the company in a report on Thursday. Bank of America reduced their price target on shares of Doximity from $56.00 to $47.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday, April 16th. Needham &amp; Company LLC reduced their price target on shares of Doximity from $55.00 to $27.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday. Finally, Jefferies Financial Group downgraded shares of Doximity from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $19.00 price target for the company. in a research report on Thursday. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and thirteen have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $31.48.</p>
<div class="lb-trans"><p>其他幾家券商也最近對 DOCS 發表了評論。羅伯特·W·貝爾德在週四的報告中重申了 “中性” 評級，並將 Doximity 的目標價格設定為 18.00 美元（從 40.00 美元下調）。BMO 資本市場將 Doximity 的目標價格從 25.00 美元下調至 20.00 美元，並在週四的報告中對該公司給予 “市場表現” 評級。美國銀行將 Doximity 的目標價格從 56.00 美元下調至 47.00 美元，並在 4 月 16 日的研究報告中對該公司給予 “買入” 評級。Needham &amp; Company LLC 將 Doximity 的目標價格從 55.00 美元下調至 27.00 美元，並在週四的研究報告中對該公司給予 “買入” 評級。最後，傑弗瑞金融集團將 Doximity 的評級從 “買入” 下調至 “持有”，併為該公司設定了 19.00 美元的目標價格。兩位分析師對該股票給予了強烈買入評級，八位給予了買入評級，十三位對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，共識目標價格為 31.48 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Doximity</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Doximity 的最新股票分析</strong></p>
</div><h2>Doximity Stock Performance</h2>
<div class="lb-trans"><h2>Doximity 股票表現</h2>
</div><ul>
<li>Doximity is an Overlooked Medical Ecosystem AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是一個被忽視的醫療生態系統 AI 投資</li>
</ul>
</div><p>DOCS stock traded down $5.93 on Thursday, hitting $17.46. 17,685,978 shares of the company's stock traded hands, compared to its average volume of 3,604,347. Doximity has a 1-year low of $17.15 and a 1-year high of $76.51. The firm has a market cap of $3.22 billion, a PE ratio of 14.64, a price-to-earnings-growth ratio of 1.88 and a beta of 1.36. The stock's fifty day moving average is $24.27.</p>
<div class="lb-trans"><p>週四，DOCS 股票下跌 5.93 美元，跌至 17.46 美元。該公司共交易了 17,685,978 股股票，而其平均交易量為 3,604,347 股。Doximity 的 1 年最低價為 17.15 美元，1 年最高價為 76.51 美元。該公司的市值為 32.2 億美元，市盈率為 14.64，市盈增長比率為 1.88，貝塔值為 1.36。該股票的 50 日移動平均線為 24.27 美元。</p>
</div><p>Doximity announced that its Board of Directors has initiated a stock repurchase program on Thursday, February 5th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to purchase up to 8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Doximity 宣佈其董事會於 2 月 5 日啓動了一項股票回購計劃，允許公司回購 5 億美元的股票。該回購授權允許公司通過公開市場購買最多 8% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><ul>
<li>Doximity Stock is an Interesting Healthcare Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 股票是一個有趣的醫療投資</li>
</ul>
</div><p>In other Doximity news, insider Siddharth Sitaram sold 2,309 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $25.77, for a total value of $59,502.93. Following the completion of the sale, the insider owned 89,396 shares in the company, valued at $2,303,734.92. This represents a 2.52% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the completion of the sale, the director owned 19,839 shares of the company's stock, valued at approximately $517,004.34. The trade was a 31.21% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 18,055 shares of company stock valued at $456,061. Company insiders own 31.30% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Doximity 新聞中，內部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股股票，平均售價為 25.77 美元，總價值為 59,502.93 美元。出售完成後，該內部人士持有 89,396 股公司股票，價值約為 2,303,734.92 美元。這代表其持股減少了 2.52%。該交易在向證券交易委員會的備案中披露，相關信息可通過此鏈接獲取。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。此外，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股股票，平均售價為 26.06 美元，總交易額為 234,540.00 美元。出售完成後，該董事持有 19,839 股公司股票，價值約為 517,004.34 美元。該交易使其持股減少了 31.21%。該出售的 SEC 備案提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。在過去三個月中，內部人士出售了價值 456,061 美元的 18,055 股公司股票。公司內部人士持有公司股票的 31.30%。</p>
</div><h2>Institutional Investors Weigh In On Doximity</h2>
<div class="lb-trans"><h2>機構投資者對 Doximity 的看法</h2>
</div><p>A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Doximity by 4.1% in the 4th quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company's stock valued at $588,281,000 after acquiring an additional 518,916 shares in the last quarter. Aubrey Capital Management Ltd bought a new position in shares of Doximity in the 3rd quarter valued at approximately $4,572,000. UBS Group AG raised its stake in shares of Doximity by 26.5% in the 4th quarter. UBS Group AG now owns 680,260 shares of the company's stock valued at $30,122,000 after acquiring an additional 142,408 shares in the last quarter. Blair William &amp; Co. IL raised its stake in shares of Doximity by 1,990.7% in the 3rd quarter. Blair William &amp; Co. IL now owns 362,740 shares of the company's stock valued at $26,534,000 after acquiring an additional 345,390 shares in the last quarter. Finally, William Blair Investment Management LLC raised its stake in shares of Doximity by 11.7% in the 3rd quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company's stock valued at $426,404,000 after acquiring an additional 609,775 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.</p>
<div class="lb-trans"><p>一些對沖基金和其他機構投資者最近增加或減少了對該股票的持股。先鋒集團在第四季度將其在 Doximity 的持股增加了 4.1%。先鋒集團目前持有 13,285,485 股公司股票，價值 588,281,000 美元，在上個季度又增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度購買了 Doximity 的新頭寸，價值約為 4,572,000 美元。瑞銀集團在第四季度將其在 Doximity 的持股增加了 26.5%。瑞銀集團目前持有 680,260 股公司股票，價值 30,122,000 美元，在上個季度又增持了 142,408 股。Blair William &amp; Co. IL 在第三季度將其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前持有 362,740 股公司股票，價值 26,534,000 美元，在上個季度又增持了 345,390 股。最後，William Blair Investment Management LLC 在第三季度將其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前持有 5,829,169 股公司股票，價值 426,404,000 美元，在上個季度又增持了 609,775 股。對沖基金和其他機構投資者持有公司股票的 87.19%。</p>
</div><h2>More Doximity News</h2>
<div class="lb-trans"><h2>更多 Doximity 新聞</h2>
</div><p>Here are the key news stories impacting Doximity this week:</p>
<div class="lb-trans"><p>以下是本週影響 Doximity 的主要新聞故事：</p>
</div><ul>
<li>Positive Sentiment: Doximity reported adjusted EPS of $0.26, which topped a lower analyst estimate of $0.17, and revenue rose 5.1% year over year to $145.37 million, showing the business is still growing. Doximity Earnings Report</li>
<li>Positive Sentiment: Management said AI tool adoption and growth in larger customers helped engagement, and the company highlighted record free cash flow and continued AI integration efforts. Doximity Q4 2026 Earnings Call Highlights</li>
<li>Neutral Sentiment: Wall Street analysts responded by cutting price targets, but most kept neutral-to-positive ratings, suggesting the stock may be viewed as oversold rather than fundamentally broken. Analyst Price Target Updates</li>
<li>Negative Sentiment: The bigger concern is that Doximity’s fiscal 2027 revenue guidance of $664 million to $676 million came in below the $696 million consensus, pointing to a slower growth outlook than investors wanted. Doximity Q4 2026 Earnings Call Transcript</li>
<li>Negative Sentiment: First-quarter fiscal 2027 revenue guidance of $151 million to $152 million also missed expectations, reinforcing worries that growth is slowing and AI-related investment is pressuring margins. Doximity plunges on weak guidance</li>
<li>Negative Sentiment: Additional sentiment pressure came from unusual put buying and a disclosed insider share sale, both of which can signal caution among traders. Insider Trade Disclosure</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：Doximity 報告調整後每股收益為 0.26 美元，超過了較低的分析師預期 0.17 美元，收入同比增長 5.1%，達到 1.4537 億美元，顯示出業務仍在增長。Doximity 財報</li>
<li>積極情緒：管理層表示，人工智能工具的採用和大型客户的增長促進了參與度，公司強調了創紀錄的自由現金流和持續的人工智能整合努力。Doximity 2026 財年第四季度財報電話會議要點</li>
<li>中性情緒：華爾街分析師通過下調目標價作出回應，但大多數保持中性至積極評級，表明該股票可能被視為超賣，而不是基本面破裂。分析師目標價更新</li>
<li>消極情緒：更大的擔憂是，Doximity 2027 財年的收入指引為 6.64 億至 6.76 億美元，低於 6.96 億美元的共識，指向比投資者預期更慢的增長前景。Doximity 2026 財年第四季度財報電話會議記錄</li>
<li>消極情緒：2027 財年第一季度收入指引為 1.51 億至 1.52 億美元，也未達到預期，進一步加深了對增長放緩和與人工智能相關的投資對利潤率施加壓力的擔憂。Doximity 因疲軟的指引大幅下跌</li>
<li>消極情緒：額外的情緒壓力來自於異常的看跌期權購買和披露的內部人士股票出售，這兩者都可能在交易者中發出謹慎信號。內部交易披露</li>
</ul>
</div><h2>About Doximity</h2>
<div class="lb-trans"><h2>關於 Doximity</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.</p>
<div class="lb-trans"><p>Doximity（股票代碼：DOCS）運營一個數字專業網絡和通信平台，主要為臨牀醫生設計。公司總部位於舊金山，連接醫生、護士執業者、醫師助理和其他醫療專業人員，提供簡化臨牀溝通、遠程醫療交付和獲取專業特定醫療信息的工具。其平台被定位為一個專業中心，臨牀醫生可以在此管理工作流程、跟進醫學新聞並與同行安全協作。</p>
</div><p>The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.</p>
<div class="lb-trans"><p>該公司的產品包括安全消息傳遞和視頻遠程醫療功能，使臨牀醫生能夠在保護患者信息的同時與患者和同事進行諮詢。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Doximity</li>
<li>YETI Rallies After Earnings Beat and Raised Outlook</li>
<li>How the 3 Leading Quantum Firms Stack Up After Q1 Earnings</li>
<li>Cisco’s Vertical Rally May Still Be in the Early Innings</li>
<li>Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Doximity</li>
<li>YETI 在財報超預期和上調前景後反彈</li>
<li>三家領先量子公司的 Q1 財報對比</li>
<li>思科的垂直反彈可能仍處於早期階段</li>
<li>亞馬遜與阿里巴巴：現在顯然更具價值的選擇</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=DOCS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Doximity Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Doximity 嗎？</h2>
</div><p>Before you consider Doximity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Doximity 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Doximity 並不在名單上。</p>
</div><p>While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Doximity 目前在分析師中獲得中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

JPMorgan Chase & Co. Lowers Doximity (NYSE:DOCS) Price Target to $28.00

Market Beat

Doximity

Langar Global HealthTech ETF

First Trust Nasdaq Lux Digital Health Solutions ETF

Global X HealthTech ETF

Defiance Daily Target 2X Long JPM ETF

摩根大通將 Doximity（紐約證券交易所代碼:DOCS）的目標股價下調至 28.00 美元